Survodutide is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research.
Also known as survodutide
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
No offer meets every pick rule today. The exact-product comparisons below still list every recorded price.
Same format. Same amount.
0 of 1 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: Survodutide COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $3.78 | $8.82 | 15 | 17 | |
| $3.78 | $8.95 | 13 | 14 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.65 | 6 | 6 |
What it is
Survodutide is under investigation in clinical trial NCT06077864 (A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)). The listed molecular formula is C192H289N47O61. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Survodutide is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| EZ Peptides | Grade A- | 1 | 1 | $78 · 10 mg vialObserved Nov 14, 2026 |
| Orbitrex Peptides | Grade A- | 1 | 1 | $99.99 · 10 mg vialObserved Nov 14, 2026 |
| Bulk Peptide Supply | Grade B+ | 1 | 1 | $27.50 · 10 mg vialObserved Nov 14, 2026 |
| Ameano Peptides | Grade B+ | 1 | 1 | $95 · 10 mg vialObserved Nov 14, 2026 |
| RUO | Grade B | 1 | 1 | $98 · 10 mg vialObserved Nov 14, 2026 |
7 tracked vendors list Survodutide without a current offer: Polaris Peptides (Grade A-), Paramount Peptides (Grade B), Nationwide Peptides (Grade B+), Peptidology (Grade C), Nuscience Peptides (Not graded), Skye Peptides (Not graded), Tydes (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.